http://www.druginjuryblog.com Brought to you by Parker Waichman Alonso LLP Thu, 18 Mar 2010 18:48:34 +0000 http://backend.userland.com/rss092 en The Medicines Company has expanded a previous recall on Cleviprex injectable emulsion because it contains visible particulate matter which could compromise a patient's health. Four more lots of Cleviprex are now included in the recall: 68-407-DJ, Exp. 08/2010; 68-408-DJ, Exp. 08/2011; 71-101-DJ and 71-106-DJ, Exp. 11/2011. The following lots were previously recalled ... http://www.druginjuryblog.com/2010/03/18/cleviprex-recall-expanded-due-to-presence-of-foreign-matter/ The law firm of Parker Waichman Alonso LLP recently commended Procter & Gamble for its decision to include a health warning about excessive zinc in its Fixodent denture creams on a product Web site, but says the company needs to do more to protect consumer safety. The firm believes P&G should ... http://www.druginjuryblog.com/2010/03/17/parker-waichman-alonso-wants-full-recall-from-pg-on-fixodent-with-zinc/ Certain frequently prescribed pills for depression and anxiety are associated with an increased risk of cataracts in the eyes, according to a Canadian study. Researchers found a statistical link between a diagnosis of cataracts or cataract surgery and some selective serotonin reuptake inhibitors. While the study found that the average time to ... http://www.druginjuryblog.com/2010/03/15/possible-cataract-risk-found-with-ssri-use/ Two women are the latest to file a lawsuit against Bayer AG over claims it made about its popular birth control Yaz. Yaz (Yasmin, Ocella) has been linked to numerous adverse side effects and in the lawsuit, filed in Ontario, Canada, the women claim it carries a four-times-greater risk of deep ... http://www.druginjuryblog.com/2010/03/11/canadian-women-file-lawsuit-over-bayer-side-effects-advertising/ The FDA says it will be conducting a safety review of certain bone-building drugs like Fosamax and Boniva to see if they increase the risk of femur fractures. The review involves a class of drugs known as bisphosphonates, which are commonly prescribed to treat osteoporosis and are designed to build bone ... http://www.druginjuryblog.com/2010/03/11/fda-to-review-osteoporosis-drugs/ The public watchdog group Public Citizen has urged the Food and Drug Administration to ban three prescription drugs: Avandia, Sibutramine and Propoxyphene. We've reported extensively on this blog about the dangers of each drug. Numerous reports on Avandia and calls for its removal from the U.S. market have been made in ... http://www.druginjuryblog.com/2010/03/10/public-citizen-urges-fda-to-ban-avandia-one-more-time/ The Supreme Court says it will decide whether federal law protects vaccine manufacturers from lawsuits seeking damages for alleged design defects. At issue was the National Childhood Vaccine Injury Act of 1986, which several state Supreme Courts are debating. There are about 5,000 claims pending under the process set out under federal ... http://www.druginjuryblog.com/2010/03/10/supreme-court-to-decide-on-lawsuits-against-vaccine-makers/ The number of lawsuits alleging GlaxoSmithKline's antidepressant drug Paxil led to infant birth defects is expected to risk after the results of the first case. According to a Public Record (Houston, Tex.) report, jurors awarded $2.5 million to the family of a child born with three congenital heart defects. At least ... http://www.druginjuryblog.com/2010/03/09/paxil-birth-defects-claims-expected-to-rise-after-plaintiff-victory-in-texas/ Regular use of aspirin, acetaminophen and other analgesics appears to substantially increase the risk of hearing loss, especially in men younger than 50. Researchers reported in the American Journal of Medicine that use of acetaminophen more than twice a week by men doubles the risk of hearing loss. Ibuprofen and related non-steroidal ... http://www.druginjuryblog.com/2010/03/09/painkillers-increase-hearing-loss-risk-in-men/ A potential $1 billion to $6 billion Avandia liability has become highlighted after more than 13,000 U.S. lawsuits were filed against GlaxoSmithKline. Worries about the diabetes drug have also surfaced, following a highly critical report from U.S. lawmakers last month. Glaxo has already underperformed by some $2.5 billion since the U.S. senators' ... http://www.druginjuryblog.com/2010/03/09/avandia-risks-increase-additional-critiques-stock-slips/